Last reviewed · How we verify
Acetium
At a glance
| Generic name | Acetium |
|---|---|
| Also known as | Acetium capsule |
| Sponsor | Biohit Oyj |
| Modality | Small molecule |
| Therapeutic area | Other |
| Phase | Phase 1 |
Approved indications
Common side effects
Key clinical trials
- The Efficacy of L-cysteine in Prevention of Cluster Headache (NA)
- The Efficacy of L-cysteine in Prevention of Headache Attacks in Migraine Patients (NA)
- The Efficacy of Acetium Lozenges in Intervention for Smoking Cessation (NA)
- L-cysteine Prevents Stomach Exposure to Carcinogenic Acetaldehyde (PHASE2)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Acetium CI brief — competitive landscape report
- Acetium updates RSS · CI watch RSS
- Biohit Oyj portfolio CI